Legal & General Group Plc - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 83 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$96,000
+21.5%
10,699
-28.5%
0.00%
Q2 2016$79,000
+17.9%
14,9560.0%0.00%
Q1 2016$67,000
+26.4%
14,956
+46.8%
0.00%
Q4 2015$53,000
-11.7%
10,1850.0%0.00%
Q3 2015$60,000
-62.5%
10,1850.0%0.00%
Q2 2015$160,000
+37.9%
10,1850.0%0.00%
Q1 2015$116,000
+6.4%
10,1850.0%0.00%
Q4 2014$109,000
+6.9%
10,1850.0%0.00%
Q3 2014$102,00010,1850.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders